Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS

NCT01133275 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome
MDS

Interventions

DRUG: Prednisone
DRUG: Lenalidomide

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]